ABOUT DIALCO

YOUR NEW PARTNER IN DIALYSIS

DIALCO RRT & HHD

Simplifying dialysis in the hospital and at home.

Dialco Medical Inc. is a wholly owned subsidiary of Spectral Medical Inc. Founded in March 2019, Dialco is focused on the commercial development of SAMI, its proprietary renal replacement machine (approved for sale by Health Canada and cleared by the FDA).

Dialco is attuned to the recent trends in the home hemodialysis (HHD) market and is actively working towards the regulatory development of its HHD machine called DIMI. Dialco is looking forward to serving the North American dialysis market.

DIALCO MEDICAL

We are a passionate team dedicated to using our experience to help simplify dialysis in the hospital and at home.

DIALCO MEDICAL

MEDICAL ADVISORY BOARD

Christopher T. Chan, MD

Christopher Chan serves as Chief of Nephrology at Toronto General Hospital, as well as Professor of Medicine at the University of Toronto and R. Fraser Elliott Chair in Home Dialysis at the University Health Network. Dr. Chan is also Associate Editor for the Clinical Journal of the American Society of Nephrology.

Jenny I. Shen, MD, MS

Jenny Shen is an Assistant Professor of Medicine and Physician Specialist within the Division of Nephrology and Hypertension at Harbor-UCLA Medical Center. Dr. Shen is an expert in home dialysis and health disparities.

Lisa Koester-Wiedemann, MSN, CS, CNN-NP

Lisa Koester-Wiedemann is a Renal Nurse Practitioner in the Division of Nephrology at Washington University and an expert in home hemodialysis and patient experience.

Fredric Finkelstein, MD

Fredric Finkelstein is Clinical Professor of Medicine at the Yale University Medical School, as well as a Nephrology Specialist and key proponent of patient-centered care. He also served as a principal investigator for the FREEDOM hemodialysis study.